Non-uniform dystrophin re-expression after CRISPR-mediated exon excision in the dystrophin/utrophin double-knockout mouse model of DMD. (2022)
Attributed to:
Antisense Oligonucleotide Therapy for Neuromuscular Disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.omtn.2022.10.010
PubMed Identifier: 36420212
Publication URI: http://europepmc.org/abstract/MED/36420212
Type: Journal Article/Review
Volume: 30
Parent Publication: Molecular therapy. Nucleic acids
ISSN: 2162-2531